Dr Juliana Maynard
Juliana Maynard is an expert Imaging Scientist specialising in pre-clinical imaging technologies, which ultimately aims to advance innovative drug discovery, bringing medicines to patients, faster. An enthusiastic, proactive, very committed and hard-working individual Juliana has worked with a broad range of imaging modalities including PET, SPECT, CT, ultrasound and MRI. She has a proven track […]
Dr Eve Corrie
Eve joined Medicines Discovery Catapult in January 2022 following her PhD in Biomedical Science at the University of Sheffield. There she focused on research into the mechanisms of chronic neuropathic pain and the use of novel, retargeted botulinum toxins to prevent or reverse it. As part of a MRC iCASE studentship, she gained experience of […]
Dr Emma Jones
Emma is a lead scientist with more than 15 years of experience investigating neuronal and glial cell function in the developing and diseased CNS across academic and industrial settings. Emma has a PhD from the University of Manchester and carried out postdoctoral research at McGill University (Montreal, Canada). In her role at Medicines Discovery Catapult, […]
Eleanor Platt
Eleanor Platt is a Molecular Scientist within the Biomarkers team at Medicines Discovery Catapult. Eleanor undertook a degree in Molecular and Cellular Biology at the University of Bath and completed her M.Phil. in Molecular Cancer Studies at the University of Manchester, with a focus on the role of glucocorticoid receptor in small cell lung cancer […]
Constance Takawira
Constance joined the team as the Partnership Manager for the CF AMR Syndicate. Constance’s main background is in clinical pharmacy, working both in the UK and in New Zealand. During her time in New Zealand, she specialised in respiratory medicine and served as a member of the antimicrobial stewardship committee. Her current focus is on […]
Dr Beverley Isherwood
Beverley has responsibility for setting up and providing strategic and scientific leadership and direction for MDC’s infectious disease Syndicate portfolio, including the CF AMR Syndicate. Bev has extensive experience in the development and delivery of collaborative research consortia bringing together experts from different sectors to shape research agendas and drive research efforts focused on unmet […]
Gayle Marshall
Gayle has more than 20 years of experience, in biomarker and omics research. Leading a large, multi-skilled translational science laboratory team, within a global Pharma department supporting biomarker strategies across 14 drug discovery programs covering more than 20 clinical studies, through to leading a large multi-disciplinary team within MDC. Gayle directs multi-biomarker analysis and assay […]
Dr Hervé Barjat
Following undergraduate studies in chemistry at Université Claude Bernard in Lyon, and an M.Sc. in physical methods of chemical analysis at UEA, he specialised in NMR spectroscopy whilst studying for a PhD at the University of Manchester with Prof. Gareth Morris. He developed novel data acquisition methods as well as analysis tools in high-field liquid-state […]
Dr Ekta Patel
Ekta is responsible for the management of the Psychiatry Consortium. Ekta is a translational scientist with over 8 years of drug discovery research experience in both academic and industrial roles. Combining her scientific knowledge and experience of working across SMEs, academic research groups and pharmaceutical companies, Ekta provides in-depth support to our collaborators to develop […]